Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A processes for acquisition targets, and establishing MSO platforms to deliver value-based oncology care nationwide.
- CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024.
- Bringing over 15 years of healthcare leadership, McInerney most recently served as the Chief Operations Officer of HOPCo Network Solutions, a subsidiary of Healthcare Outcomes Performance Co. (HOPCo).
- "We are delighted to welcome Jordan McInerney to The Oncology Institute as our new Chief Development Officer," stated Dr. Daniel Virnich, Chief Executive Officer at The Oncology Institute.
- "I am deeply honored to join The Oncology Institute and to spearhead development efforts for such a remarkable organization dedicated to advancing value-based cancer care," expressed McInerney.